Show simple item record

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

dc.contributor.authorFransen, Jaapen_US
dc.contributor.authorJohnson, Sindhu R.en_US
dc.contributor.authorvan den Hoogen, Franken_US
dc.contributor.authorBaron, Murrayen_US
dc.contributor.authorAllanore, Yannicken_US
dc.contributor.authorCarreira, Patricia E.en_US
dc.contributor.authorCzirják, Lászlóen_US
dc.contributor.authorDenton, Christopher P.en_US
dc.contributor.authorDistler, Oliveren_US
dc.contributor.authorFurst, Daniel E.en_US
dc.contributor.authorGabrielli, Armandoen_US
dc.contributor.authorHerrick, Arianeen_US
dc.contributor.authorInanc, Muraten_US
dc.contributor.authorKahaleh, Basharen_US
dc.contributor.authorKowal‐bielecka, Otyliaen_US
dc.contributor.authorMedsger, Thomas A.en_US
dc.contributor.authorMueller‐ladner, Ulfen_US
dc.contributor.authorRiemekasten, Gabrielaen_US
dc.contributor.authorSierakowski, Stanislawen_US
dc.contributor.authorValentini, Gabrieleen_US
dc.contributor.authorVeale, Dougen_US
dc.contributor.authorVonk, Madelon C.en_US
dc.contributor.authorWalker, Ulrichen_US
dc.contributor.authorChung, Lorindaen_US
dc.contributor.authorClements, Philip J.en_US
dc.contributor.authorCollier, David H.en_US
dc.contributor.authorCsuka, Mary E.en_US
dc.contributor.authorJimenez, Sergioen_US
dc.contributor.authorMerkel, Peter A.en_US
dc.contributor.authorSeibold, James R.en_US
dc.contributor.authorSilver, Richarden_US
dc.contributor.authorSteen, Virginiaen_US
dc.contributor.authorTyndall, Alanen_US
dc.contributor.authorMatucci‐cerinic, Marcoen_US
dc.contributor.authorPope, Janet E.en_US
dc.contributor.authorKhanna, Dineshen_US
dc.date.accessioned2012-03-16T15:57:49Z
dc.date.available2013-05-01T17:24:40Zen_US
dc.date.issued2012-03en_US
dc.identifier.citationFransen, Jaap; Johnson, Sindhu R.; van den Hoogen, Frank; Baron, Murray; Allanore, Yannick; Carreira, Patricia E.; Czirják, László ; Denton, Christopher P.; Distler, Oliver; Furst, Daniel E.; Gabrielli, Armando; Herrick, Ariane; Inanc, Murat; Kahaleh, Bashar; Kowal‐bielecka, Otylia ; Medsger, Thomas A.; Mueller‐ladner, Ulf ; Riemekasten, Gabriela; Sierakowski, Stanislaw; Valentini, Gabriele; Veale, Doug; Vonk, Madelon C.; Walker, Ulrich; Chung, Lorinda; Clements, Philip J.; Collier, David H.; Csuka, Mary E.; Jimenez, Sergio; Merkel, Peter A.; Seibold, James R.; Silver, Richard; Steen, Virginia; Tyndall, Alan; Matucci‐cerinic, Marco ; Pope, Janet E.; Khanna, Dinesh (2012). "Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise." Arthritis Care & Research 64(3): 351-357. <http://hdl.handle.net/2027.42/90249>en_US
dc.identifier.issn2151-464Xen_US
dc.identifier.issn2151-4658en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90249
dc.description.abstractObjective Classification criteria for systemic sclerosis (SSc; scleroderma) are being updated. Our objective was to select a set of items potentially useful for the classification of SSc using consensus procedures, including the Delphi and nominal group techniques (NGT). Methods Items were identified through 2 independent consensus exercises performed by the Scleroderma Clinical Trials Consortium and the European League Against Rheumatism Scleroderma Trials and Research Group. The first‐round items from both exercises were collated and redundancies were removed, leaving 168 items. A 3‐round Delphi exercise was performed using a 1–9 scale (where 1 = completely inappropriate and 9 = completely appropriate) and a consensus meeting using NGT was conducted. During the last Delphi round, the items were ranked on a 1–10 scale. Results In round 1, 106 experts rated the 168 items. Those with a median score of <4 were removed, resulting in a list of 102 items. In round 2, the items were again rated for appropriateness and subjected to a consensus meeting using NGT by European and North American SSc experts (n = 16), resulting in 23 items. In round 3, SSc experts (n = 26) then individually scored each of the 23 items in a last Delphi round using an appropriateness score ( 1–9 ) and ranking their 10 most appropriate items for the classification of SSc. Presence of skin thickening, SSc‐specific autoantibodies, abnormal nailfold capillary pattern, and Raynaud's phenomenon ranked highest in the final list that also included items indicating internal organ involvement. Conclusion The Delphi exercise and NGT resulted in a set of 23 items for the classification of SSc that will be assessed for their discriminative properties in a prospective study.en_US
dc.publisherJohn Wiley & Sons, Inc.en_US
dc.titleItems for developing revised classification criteria in systemic sclerosis: Results of a consensus exerciseen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Scleroderma Program, Ann Arboren_US
dc.contributor.affiliationumUniversity of Michigan Scleroderma Program, Division of Rheumatology/Department of Internal Medicine, 24 Frank Lloyd Wright Drive, Lobby M, Suite 2500, SPC 5753, PO Box 481, Ann Arbor, MI 48106en_US
dc.contributor.affiliationotherMedical College of Wisconsin, Milwaukeeen_US
dc.contributor.affiliationotherRadboud University Nijmegen Medical Center, Nijmegen, The Netherlandsen_US
dc.contributor.affiliationotherToronto Western Hospital, Mount Sinai Hospital, and University of Toronto, Toronto, Ontario, Canadaen_US
dc.contributor.affiliationotherMaartenskliniek, Nijmegen, The Netherlandsen_US
dc.contributor.affiliationotherMcGill University, Jewish General Hospital, Montreal, Quebec, Canadaen_US
dc.contributor.affiliationotherUniversité Paris Descartes, Hôpital Cochin, AP‐HP, Paris, Franceen_US
dc.contributor.affiliationotherHospital Universitario 12 de Octubre, Madrid, Spainen_US
dc.contributor.affiliationotherMedical School, University of Pécs, Pécs, Hungaryen_US
dc.contributor.affiliationotherRoyal Free Hospital, London, UKen_US
dc.contributor.affiliationotherUniversity Hospital Zurich, Zurich, Switzerlanden_US
dc.contributor.affiliationotherDavid Geffen School of Medicine, University of California, Los Angelesen_US
dc.contributor.affiliationotherClinica Medica, Università Politecnica delle Marche, Ancona, Italyen_US
dc.contributor.affiliationotherUniversity of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UKen_US
dc.contributor.affiliationotherIstanbul University, Istanbul, Turkeyen_US
dc.contributor.affiliationotherUniversity of Toledo, Toledo, Ohioen_US
dc.contributor.affiliationotherMedical University of Bialystok, Bialystok, Polanden_US
dc.contributor.affiliationotherUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvaniaen_US
dc.contributor.affiliationotherJustus‐Liebig University Giessen, Giessen, and Kerckhoff‐Clinic Bad Nauheim, Bad Nauheim, Germanyen_US
dc.contributor.affiliationotherCharité University Hospital Berlin and German Rheumatism Research Centre, Berlin, Germanyen_US
dc.contributor.affiliationotherSecond University of Naples, Naples, Italyen_US
dc.contributor.affiliationotherSt. Vincent's University Hospital and The Conway Institute for Biomedical and Biomolecular Research, University College Dublin, Dublin, Irelanden_US
dc.contributor.affiliationotherUniversity of Basel, Basel, Switzerlanden_US
dc.contributor.affiliationotherStanford University, Stanford, Californiaen_US
dc.contributor.affiliationotherDenver Health and Hospital Authority, University of Colorado Hospital, Denveren_US
dc.contributor.affiliationotherJefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, Pennsylvaniaen_US
dc.contributor.affiliationotherBoston University School of Medicine, Boston, Massachusettsen_US
dc.contributor.affiliationotherScleroderma Research Consultants, Avon, Connecticuten_US
dc.contributor.affiliationotherMedical University of South Carolina, Charlestonen_US
dc.contributor.affiliationotherGeorgetown University School of Medicine, Washington, DCen_US
dc.contributor.affiliationotherAzienda Ospedaliero‐Universitaria Careggi, Denothe Centre, University of Florence, Florence, Italyen_US
dc.contributor.affiliationotherUniversity of Western Ontario, St. Joseph's Health Care London, University of Western Ontario, Schulich School of Medicine & Dentistry, London, Ontario, Canadaen_US
dc.contributor.affiliationotherAmgen, Thousand Oaks, Californiaen_US
dc.identifier.pmid22052558en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90249/1/20679_ftp.pdf
dc.identifier.doi10.1002/acr.20679en_US
dc.identifier.sourceArthritis Care & Researchen_US
dc.identifier.citedreferenceWollheim FA. Classification of systemic sclerosis: visions and reality. Rheumatology (Oxford) 2005; 44: 1212 – 6.en_US
dc.identifier.citedreferenceCharles C, Clements P, Furst DE. Systemic sclerosis: hypothesis‐driven treatment strategies. Lancet 2006; 367: 1683 – 91.en_US
dc.identifier.citedreferenceCoulter C, Canadian Scleroderma Research Group, Scleroderma Clinical Trials Consortium, Hudson M, Steele R, Baron M, et al. The development of updated criteria for systemic sclerosis (SSc) using Delphi technique and cluster and frequency analyses from a large SSc patient database [abstract]. Arthritis Rheum 2009; 60 Suppl: S652.en_US
dc.identifier.citedreferenceJohnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger TA Jr, et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken) 2012; 64: 358 – 67.en_US
dc.identifier.citedreferenceSteen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35: 35 – 42.en_US
dc.identifier.citedreferenceCutolo M, Matucci CM. Nailfold capillaroscopy and classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007; 25: 663 – 5.en_US
dc.identifier.citedreferenceBaron M, Bell M, Bookman A, Buchignani M, Dunne J, Hudson M, et al. Office capillaroscopy in systemic sclerosis. Clin Rheumatol 2007; 26: 1268 – 74.en_US
dc.identifier.citedreferenceMaricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983; 1: 195 – 205.en_US
dc.identifier.citedreferenceRodnan GP, Jablonska S, Medsger TA. Classification and nomenclature of progressive systemic sclerosis. Clin Rheum Dis 1979; 5: 5 – 13.en_US
dc.identifier.citedreferenceClements PJ. Systemic sclerosis (scleroderma) and related disorders: clinical aspects. Baillieres Best Pract Res Clin Rheumatol 2000; 14: 1 – 16.en_US
dc.identifier.citedreferenceMerkel PA, Clements PJ, Reveille JD, Suarez‐Almazor ME, Valentini G, Furst DE. Current status of outcome measure development for clinical trials in systemic sclerosis: report from OMERACT 6. J Rheumatol 2003; 30: 1630 – 47.en_US
dc.identifier.citedreferenceWigley FM, Hummers L. Management: holistic approach to systemic sclerosis. Physician's approach. In: Clements PJ, Furst DE, editors. Systemic sclerosis. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 371 – 84.en_US
dc.identifier.citedreferenceSterz M, McCloskey D. Management: holistic approach to systemic sclerosis. Nurse's approach. In: Clements PJ, Furst DE, editors. Systemic sclerosis. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 385 – 92.en_US
dc.identifier.citedreferenceLeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202 – 5.en_US
dc.identifier.citedreferenceLonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma [letter]. Arthritis Rheum 2001; 44: 735 – 6.en_US
dc.identifier.citedreferenceNair R, Aggarwal R, Khanna D. Methods of formal consensus in classification/diagnostic criteria and guideline development. Semin Arthritis Rheum 2011; 41: 95 – 105.en_US
dc.identifier.citedreferenceMukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088 – 93.en_US
dc.identifier.citedreferenceKhanna D, Denton CP. Evidence‐based management of rapidly progressing systemic sclerosis. Best Pract Res Clin Rheumatol 2010; 24: 387 – 400.en_US
dc.identifier.citedreferenceSteen VD, Lucas M, Fertig N, Medsger TA Jr. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody. J Rheumatol 2007; 34: 2230 – 5.en_US
dc.identifier.citedreferenceLeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573 – 6.en_US
dc.identifier.citedreferenceHarper FE, Maricq HR, Turner RE, Lidman RW, LeRoy EC. A prospective study of Raynaud phenomenon and early connective tissue disease: a five‐year report. Am J Med 1982; 72: 883 – 8.en_US
dc.identifier.citedreferenceMaricq HR, Weinberger AB, LeRoy EC. Early detection of scleroderma‐spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon. J Rheumatol 1982; 9: 289 – 91.en_US
dc.identifier.citedreferenceKoenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty‐year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008; 58: 3902 – 12.en_US
dc.identifier.citedreferenceHachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 2011; 40: 78 – 83.en_US
dc.identifier.citedreferenceWalker JG, Pope J, Baron M, Leclercq S, Hudson M, Taillefer S, et al. The development of systemic sclerosis classification criteria. Clin Rheumatol 2007; 26: 1401 – 9.en_US
dc.identifier.citedreferenceAvouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi consensus study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 2011; 70: 476 – 81.en_US
dc.identifier.citedreferenceSubcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581 – 90.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.